Ken Griffin Shattuck Labs, Inc. Put Options Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
Put Options
3 transactions
Others Institutions Holding STTK
# of Institutions
73Shares Held
23.2MCall Options Held
130KPut Options Held
163K-
Redmile Group, LLC San Francisco, CA5.62MShares$24.7 Million1.98% of portfolio
-
Prosight Management, LP Dallas, TX3.73MShares$16.4 Million9.58% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.37MShares$10.4 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.82MShares$8.01 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.66MShares$7.32 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $186M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...